TrialClinical and vaccine immunology : CVI2016

Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial.

Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.